Cosmax, a global cosmetics ODM (research, development, and production) company, will develop new functional materials that ...

Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR study evaluating brepocitinib, a potential new treatment for the autoimmune disease ...

Outstanding measure of efficacy relative to high-risk cancers with limited treatment options CHICAGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ("MAIA", the "Com ...

A team of researchers from Tel Aviv University and the Israel Oceanographic and Limnological Research Institute (IOLR) has ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today ...

Nagaland University researchers have identified Sinapic acid, a natural plant compound, as a potential breakthrough for treating diabetic wounds. This ...

PranaX Corporation, a leading biotechnology company specializing in regenerative biologics, has announced that a study concerning the exosome manufacturing technology exclusively licensed for ...

During the COVID-19 pandemic, AI-assisted sequencing pipelines were instrumental in tracking SARS-CoV-2 variants, ...

Using CRISPR-based genetic engineering, the team further identified mutations in viral genes that prevent activation, ...

“Our work is the first to directly test how chromosome structure affects bacterial growth, survival, and ability to cause ...